Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a monoclonal antibody for the treatment of osteoporosis. 3D rendering based on protein data bank entry 2kd3. Cartoon representatio